Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement.

Maffei R, Fiorcari S, Martinelli S, Guarnotta C, Benatti S, Belmonte B, Potenza L, Luppi M, Marasca R.

Hematol Oncol. 2018 Feb;36(1):372-375. doi: 10.1002/hon.2448. Epub 2017 Jun 4. No abstract available.

PMID:
28580615
2.

Mast cells are associated with the onset and progression of celiac disease.

Frossi B, Tripodo C, Guarnotta C, Carroccio A, De Carli M, De Carli S, Marino M, Calabrò A, Pucillo CE.

J Allergy Clin Immunol. 2017 Apr;139(4):1266-1274.e1. doi: 10.1016/j.jaci.2016.08.011. Epub 2016 Sep 13.

PMID:
27619824
3.

C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.

Bulla R, Tripodo C, Rami D, Ling GS, Agostinis C, Guarnotta C, Zorzet S, Durigutto P, Botto M, Tedesco F.

Nat Commun. 2016 Feb 1;7:10346. doi: 10.1038/ncomms10346.

4.

Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10+ phenotype.

Betto E, Usuelli V, Mandelli A, Badami E, Sorini C, Capolla S, Danelli L, Frossi B, Guarnotta C, Ingrao S, Tripodo C, Pucillo C, Gri G, Falcone M.

Clin Immunol. 2017 May;178:29-38. doi: 10.1016/j.clim.2015.12.013. Epub 2015 Dec 28.

PMID:
26732858
5.

Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma.

Ferretti E, Di Carlo E, Ognio E, Guarnotta C, Bertoni F, Corcione A, Prigione I, Fraternali-Orcioni G, Ribatti D, Ravetti JL, Ponzoni M, Tripodo C, Pistoia V.

Oncoimmunology. 2015 Jun 19;4(10):e1030560. eCollection 2015 Oct.

6.

Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth.

Rigoni A, Bongiovanni L, Burocchi A, Sangaletti S, Danelli L, Guarnotta C, Lewis A, Rizzo A, Silver AR, Tripodo C, Colombo MP.

Cancer Res. 2015 Sep 15;75(18):3760-70. doi: 10.1158/0008-5472.CAN-14-3767. Epub 2015 Jul 23.

7.

D2-40 negative pyogenic granuloma-like Kaposi's sarcoma: Diagnostic features and histogenetic hypothesis of an uncommon skin tumor in HIV-negative patients.

Cabibi D, Giannone AG, Guarnotta C, Schillaci O, Franco V.

Pathol Res Pract. 2015 Jul;211(7):528-32. doi: 10.1016/j.prp.2015.03.006. Epub 2015 Apr 2.

PMID:
25939289
8.

SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias.

Vitali C, Bassani C, Chiodoni C, Fellini E, Guarnotta C, Miotti S, Sangaletti S, Fuligni F, De Cecco L, Piccaluga PP, Colombo MP, Tripodo C.

Cancer Res. 2015 Jun 1;75(11):2387-99. doi: 10.1158/0008-5472.CAN-14-3625. Epub 2015 Apr 9.

9.

HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.

Zappasodi R, Ruggiero G, Guarnotta C, Tortoreto M, Tringali C, Cavanè A, Cabras AD, Castagnoli L, Venerando B, Zaffaroni N, Gianni AM, De Braud F, Tripodo C, Pupa SM, Di Nicola M.

Blood. 2015 Mar 12;125(11):1768-71. doi: 10.1182/blood-2014-07-590034. Epub 2015 Jan 8.

PMID:
25573990
10.

Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment.

Danelli L, Frossi B, Gri G, Mion F, Guarnotta C, Bongiovanni L, Tripodo C, Mariuzzi L, Marzinotto S, Rigoni A, Blank U, Colombo MP, Pucillo CE.

Cancer Immunol Res. 2015 Jan;3(1):85-95. doi: 10.1158/2326-6066.CIR-14-0102. Epub 2014 Oct 28.

11.

The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.

Ferretti E, Tripodo C, Pagnan G, Guarnotta C, Marimpietri D, Corrias MV, Ribatti D, Zupo S, Fraternali-Orcioni G, Ravetti JL, Pistoia V, Corcione A.

Leukemia. 2015 Apr;29(4):958-67. doi: 10.1038/leu.2014.291. Epub 2014 Oct 6.

PMID:
25283844
12.

The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients.

Petta S, Grimaudo S, Tripodo C, Cabibi D, Calvaruso M, Di Cristina A, Guarnotta C, Macaluso FS, Minissale MG, Marchesini G, Craxì A.

J Clin Endocrinol Metab. 2015 Jan;100(1):193-200. doi: 10.1210/jc.2014-2741.

PMID:
25268393
13.

Mast cells control the expansion and differentiation of IL-10-competent B cells.

Mion F, D'Incà F, Danelli L, Toffoletto B, Guarnotta C, Frossi B, Burocchi A, Rigoni A, Gerdes N, Lutgens E, Tripodo C, Colombo MP, Rivera J, Vitale G, Pucillo CE.

J Immunol. 2014 Nov 1;193(9):4568-79. doi: 10.4049/jimmunol.1302593. Epub 2014 Sep 29.

14.

Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies.

Sangaletti S, Tripodo C, Portararo P, Dugo M, Vitali C, Botti L, Guarnotta C, Cappetti B, Gulino A, Torselli I, Casalini P, Chiodoni C, Colombo MP.

Oncoimmunology. 2014 Jun 5;3:e28989. eCollection 2014.

15.

PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells.

Plantamura I, Casalini P, Dugnani E, Sasso M, D'Ippolito E, Tortoreto M, Cacciatore M, Guarnotta C, Ghirelli C, Barajon I, Bianchi F, Triulzi T, Agresti R, Balsari A, Campiglio M, Tripodo C, Iorio MV, Tagliabue E.

Mol Oncol. 2014 Jul;8(5):968-81. doi: 10.1016/j.molonc.2014.03.015. Epub 2014 Mar 27.

16.

Immunohistochemical/histochemical double staining method in the study of the columnar metaplasia of the oesophagus.

Cabibi D, Giannone AG, Mascarella C, Guarnotta C, Castiglia M, Pantuso G, Fiorentino E.

Eur J Histochem. 2014 Mar 5;58(1):2326. doi: 10.4081/ejh.2014.2326.

17.

Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.

Zappasodi R, Cavanè A, Iorio MV, Tortoreto M, Guarnotta C, Ruggiero G, Piovan C, Magni M, Zaffaroni N, Tagliabue E, Croce CM, Zunino F, Gianni AM, Di Nicola M.

Int J Cancer. 2014 Nov 1;135(9):2034-45. doi: 10.1002/ijc.28852. Epub 2014 Mar 26. Erratum in: Int J Cancer. 2017 Nov 1;141(9):E6.

18.

C1q as a unique player in angiogenesis with therapeutic implication in wound healing.

Bossi F, Tripodo C, Rizzi L, Bulla R, Agostinis C, Guarnotta C, Munaut C, Baldassarre G, Papa G, Zorzet S, Ghebrehiwet B, Ling GS, Botto M, Tedesco F.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4209-14. doi: 10.1073/pnas.1311968111. Epub 2014 Mar 3.

19.

Challenges and new prospects in hepatosplenic γδ T-cell lymphoma.

Calvaruso M, Gulino A, Buffa S, Guarnotta C, Franco G, Cacciatore M, Bonura MG, Franco V, Florena AM.

Leuk Lymphoma. 2014 Nov;55(11):2457-65. doi: 10.3109/10428194.2014.889821. Epub 2014 Mar 10. Review.

PMID:
24506469
20.

Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma.

Franco G, Guarnotta C, Frossi B, Piccaluga PP, Boveri E, Gulino A, Fuligni F, Rigoni A, Porcasi R, Buffa S, Betto E, Florena AM, Franco V, Iannitto E, Arcaini L, Pileri SA, Pucillo C, Colombo MP, Sangaletti S, Tripodo C.

Blood. 2014 Mar 20;123(12):1836-49. doi: 10.1182/blood-2013-04-497271. Epub 2014 Jan 22.

PMID:
24452203
21.

Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma.

Sangaletti S, Tripodo C, Vitali C, Portararo P, Guarnotta C, Casalini P, Cappetti B, Miotti S, Pinciroli P, Fuligni F, Fais F, Piccaluga PP, Colombo MP.

Cancer Discov. 2014 Jan;4(1):110-29. doi: 10.1158/2159-8290.CD-13-0276. Epub 2013 Nov 4.

22.

IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.

Ciccia F, Alessandro R, Rodolico V, Guggino G, Raimondo S, Guarnotta C, Giardina A, Sireci G, Campisi G, De Leo G, Triolo G.

Rheumatology (Oxford). 2013 Jun;52(6):1009-17. doi: 10.1093/rheumatology/kes435. Epub 2013 Feb 7.

PMID:
23392590
23.

The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.

Maffei R, Bulgarelli J, Fiorcari S, Bertoncelli L, Martinelli S, Guarnotta C, Castelli I, Deaglio S, Debbia G, De Biasi S, Bonacorsi G, Zucchini P, Narni F, Tripodo C, Luppi M, Cossarizza A, Marasca R.

Haematologica. 2013 Jul;98(7):1115-23. doi: 10.3324/haematol.2012.073080. Epub 2013 Jan 24.

24.

Human dental pulp cell apoptosis: immunohistochemical study after applying orthodontic traction.

Leone A, Angelova Volponi A, Campanella C, Guarnotta C, Abdallah Hajj Hussein I, Cappello F, Gerbino A, Jurjus A.

J Biol Regul Homeost Agents. 2012 Oct-Dec;26(4):713-20.

PMID:
23241121
25.

Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model.

Rossini A, Giussani M, Giacomini A, Guarnotta C, Tagliabue E, Balsari A.

Breast Cancer Res Treat. 2012 Nov;136(2):457-67. doi: 10.1007/s10549-012-2281-4. Epub 2012 Oct 11.

26.

Evaluation of thermoresponsive properties and biocompatibility of polybenzofulvene aggregates for leuprolide delivery.

Licciardi M, Amato G, Cappelli A, Paolino M, Giuliani G, Belmonte B, Guarnotta C, Pitarresi G, Giammona G.

Int J Pharm. 2012 Nov 15;438(1-2):279-86. doi: 10.1016/j.ijpharm.2012.09.023. Epub 2012 Sep 16.

PMID:
22989982
27.

Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion.

Tripodo C, Sangaletti S, Guarnotta C, Piccaluga PP, Cacciatore M, Giuliano M, Franco G, Chiodoni C, Sciandra M, Miotti S, Calvaruso G, Carè A, Florena AM, Scotlandi K, Orazi A, Pileri SA, Colombo MP.

Blood. 2012 Oct 25;120(17):3541-54. doi: 10.1182/blood-2011-12-398537. Epub 2012 Sep 5.

PMID:
22955913
28.

Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity.

Sangaletti S, Tripodo C, Chiodoni C, Guarnotta C, Cappetti B, Casalini P, Piconese S, Parenza M, Guiducci C, Vitali C, Colombo MP.

Blood. 2012 Oct 11;120(15):3007-18. doi: 10.1182/blood-2012-03-416156. Epub 2012 Aug 29.

PMID:
22932797
29.

Microenvironment-centred dynamics in aggressive B-cell lymphomas.

Cacciatore M, Guarnotta C, Calvaruso M, Sangaletti S, Florena AM, Franco V, Colombo MP, Tripodo C.

Adv Hematol. 2012;2012:138079. doi: 10.1155/2012/138079. Epub 2012 Feb 19.

30.

Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients.

Tripodo C, Petta S, Guarnotta C, Pipitone R, Cabibi D, Colombo MP, Craxì A.

Antivir Ther. 2012;17(1):111-8. doi: 10.3851/IMP1957.

PMID:
22267475
31.

Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.

Cabibi D, Aragona F, Guarnotta C, Rodolico V, Zerilli M, Belmonte B, Schillaci L, Aragona F.

Appl Immunohistochem Mol Morphol. 2011 May;19(3):239-45. doi: 10.1097/PAI.0b013e3181f7b2f0.

PMID:
21475039
32.

Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection.

Petta S, Cammà C, Di Marco V, Macaluso FS, Maida M, Pizzolanti G, Belmonte B, Cabibi D, Di Stefano R, Ferraro D, Guarnotta C, Venezia G, Craxì A.

Liver Int. 2011 Apr;31(4):507-15. doi: 10.1111/j.1478-3231.2011.02453.x. Epub 2011 Jan 30.

PMID:
21382161
33.

An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development.

Agostinis C, Bulla R, Tripodo C, Gismondi A, Stabile H, Bossi F, Guarnotta C, Garlanda C, De Seta F, Spessotto P, Santoni A, Ghebrehiwet B, Girardi G, Tedesco F.

J Immunol. 2010 Oct 1;185(7):4420-9. doi: 10.4049/jimmunol.0903215. Epub 2010 Sep 1.

34.

Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma.

Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese S, Franco G, Vetri V, Pucillo CE, Florena AM, Colombo MP, Pileri SA.

Am J Pathol. 2010 Aug;177(2):792-802. doi: 10.2353/ajpath.2010.091286. Epub 2010 Jul 1.

35.

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.

Maffei R, Martinelli S, Santachiara R, Rossi D, Guarnotta C, Sozzi E, Zucchetto A, Rigolin GM, Fiorcari S, Castelli I, Fontana M, Coluccio V, Leonardi G, Zucchini P, Tripodo C, Cuneo A, Gattei V, Del Poeta G, Forconi F, Gaidano G, Torelli G, Marasca R.

Blood. 2010 Jul 29;116(4):584-92. doi: 10.1182/blood-2009-11-252494. Epub 2010 Apr 9.

PMID:
20382847
36.

Humoral immunotherapy of multiple myeloma: perspectives and perplexities.

Di Bernardo A, Macor P, Guarnotta C, Franco G, Florena AM, Tedesco F, Tripodo C.

Expert Opin Biol Ther. 2010 Jun;10(6):863-73. doi: 10.1517/14712591003774063. Review.

PMID:
20367529
37.

P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma.

Tripodo C, Florena AM, Macor P, Di Bernardo A, Porcasi R, Guarnotta C, Ingrao S, Zerilli M, Secco E, Todaro M, Tedesco F, Franco V.

Curr Cancer Drug Targets. 2009 Aug;9(5):617-25.

PMID:
19508173
38.

'Pyogenic granuloma-like Kaposi's sarcoma' on the hands: immunohistochemistry and human herpesvirus-8 detection.

Cabibi D, Cacciatore M, Viviano E, Guarnotta C, Aragona F.

J Eur Acad Dermatol Venereol. 2009 May;23(5):587-9. No abstract available.

PMID:
19415811
39.

Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis.

Florena AM, Tripodo C, Di Bernardo A, Iannitto E, Guarnotta C, Porcasi R, Ingrao S, Abbadessa V, Franco V.

J Clin Pathol. 2009 Apr;62(4):331-8. doi: 10.1136/jcp.2007.054353.

PMID:
19329711
40.

CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis.

Tripodo C, Di Bernardo A, Ternullo MP, Guarnotta C, Porcasi R, Ingrao S, Gianelli U, Boveri E, Iannitto E, Franco G, Florena AM.

Haematologica. 2009 Jan;94(1):127-30. doi: 10.3324/haematol.13598. Epub 2008 Nov 23.

41.

Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye.

Secchiero P, Lamberti G, Corallini F, Melloni E, Guarnotta C, Sebastiani A, Zauli G.

J Cell Physiol. 2009 Jan;218(1):199-204. doi: 10.1002/jcp.21589.

PMID:
18780288
42.

Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients.

Florena AM, Tripodo C, Guarnotta C, Ingrao S, Porcasi R, Martorana A, Lo Bosco G, Cabibi D, Franco V.

Pathobiology. 2007;74(6):317-22. Epub 2007 Dec 13.

43.
44.

C1q production by bone marrow stromal cells.

Tripodo C, Porcasi R, Guarnotta C, Ingrao S, Campisi V, Florena AM, Franco V.

Scand J Immunol. 2007 Mar;65(3):308-9. No abstract available.

45.

Constant detection of cyclooxygenase 2 in terminal stages of myeloid maturation.

Tripodo C, Florena AM, Porcasi R, Ingrao S, Guarnotta C, Franco V.

Acta Haematol. 2007;117(1):48-50. Epub 2006 Nov 8. No abstract available.

PMID:
17095859

Supplemental Content

Loading ...
Support Center